OpenLegislation

The Misuse of Drugs Act 1971 (Modification) Order 2003

S.I. 2003/1243 · Made 8 May 2003

Original text. legislation.gov.uk does not revise statutory instruments, so later amendments are not shown here. Changes made to it are listed under each provision when known.

DANGEROUS DRUGS

Made 8th May 2003

Coming into force 1st July 2003

At the Court at Buckingham Palace, the 8th day of May 2003

Present,

The Queen’s Most Excellent Majesty in Council

Whereas a draft of this Order has been laid before Parliament on the recommendation of the Advisory Council on the Misuse of Drugs and has been approved by a resolution of each House of Parliament;

Now, therefore, Her Majesty, in pursuance of section 2(2) of the Misuse of Drugs Act 1971f1, is pleased, by and with the advice of Her Privy Council, to order, and it is hereby ordered, as follows:—

Annotations to the whole text

Footnotes

f1

1971 c. 38.

Contents

  1. 1Article 1
  2. 2Article 2
  3. Signature
  4. Explanatory note

1

This Order shall be cited as the Misuse of Drugs Act 1971 (Modification) Order 2003 and shall come into force on 1st July 2003.

2

(1)

Schedule 2 to the Misuse of Drugs Act 1971f1 (which specifies the drugs which are subject to control under that Act) shall be amended as follows:

(2)

In paragraph 1(a) of Part I of that Schedule there shall be inserted—

(a)

after “Dihydrocodeinone O-carboxymethyloxime”, “Dihydroetorphine”; and

(b)

after “Racemorphan”, “Remifentanil.”.

(3)

In paragraph 1(a) of Part III of that Schedule, there shall be inserted—

(a)

after “Haloxazolam”, “4-Hydroxy-n-butyric acid”; and

(b)

after “N-Ethylamphetamine”, “Zolpidem”.

(4)

In paragraph 1(b) of Part III of that Schedule, there shall be inserted—

(a)

before “Atamestane”, “4-Androstene-3, 17-dione” and “5-Androstene-3, 17-diol”; and

(b)

after “Nandrolone”, “19-Nor-4-Androstene-3, 17-dione”; and “19-Nor-5-Androstene-3, 17-diol”.

Signature

A. K. Galloway

Clerk of the Privy Council

Explanatory note

(This note is not part of the Order)

This Order adds eight substances to Schedule 2 to the Misuse of Drugs Act 1971 which specifies drugs which are subject to control under the Act. Two of the substances, Dihydroetorphine and Remifentanil, are added as Class A drugs; and the remaining six, 4-Androstene-3, 17-dione; 5-Androstene-3, 17-diol; 4-Hydroxy-n-butyric acid; 19-Nor-4-Androstene-3; 17-dione, 19-Nor-5-Androstene-3, 17-diol and Zolpidem, are added as Class C drugs.